Abstract:Omer Ahmed Hamad Amin, 1 Raouf Rahim Mirza, 2 Hiwa Abubakr Hussein, 2 Zhikal Omar Khudhur, 3 Harem Khdir Awla, 4 Shukur Wasman Smail 4, 5 1 Department of Rheumatology, Ranya Teaching Hospital, Ministry of Health, Ranya, Kurdistan Region, Iraq; 2 College of Medicine, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq; 3 Biology Education Department, Tishk International University, Erbil, Iraq; 4 Department of Biology, College of Science, Salahaddin University, Erbil, Kurdistan Region, Iraq; 5 Department of Medical Microbiology, College of Science, Cihan University-Erbil, Kurdistan Region, Iraq Correspondence: Shukur Wasman Smail, Department of Biology, College of Science, Salahaddin University, Erbil, Kurdistan Region, Iraq, Tel +9647504491092, Email Purpose: Systemic Sclerosis (SSc) is a rare connective tissue disorder characterized by autoimmunity, fibrosis, and vasculopathy that affects the skin and internal organs, including the gastrointestinal tract, particularly the esophagus. This article highlights the characteristics and clinical symptoms of esophageal involvement in patients with SSc. Patients and Methods: This study was conducted between November 2022 to August 2023, including 26 already diagnosed cases of SSc in the Department of Rheumatology and Rehabilitation and Kurdistan Center for Gastroenterology and Hepatology-Sulaymaniyah, Iraq. Esophageal involvement was investigated using esophageal manometry, esophagogastroduodenoscopy (EGD), and 24-hour impedance-pH monitoring. Results: Females were significantly predominant ( P = 0.019) regarding the symptoms; 76.9% of the patients had heart burn, 76.9% dysphagia, 73.1% water brush, and 69.2% regurgitation. In total, 69.2% of the patients showed erosive gastrointestinal reflux disease (GERD) on EGD, 76.9% had decreased lower esophageal sphincter pressure (DLESP) and decreased distal esophageal peristaltic contractions (DDEPC) on esophageal manometry, and 84.6% had reflux on pH monitoring. Raynaud's phenomenon is the most common and typically the earliest clinical manifestation of SSc. The presence of erosive GERD was found to significantly increase the risk of developing dysphagia (B = 4.725, P = 0.014, OR = 3.482) and regurgitation (B = 3.521, P = 0.006, OR = 4.030). Conclusion: It is crucial to take gender-specific considerations into account when diagnosing and managing esophageal complications in patients with systemic sclerosis (SSc). Additionally, employing various diagnostic assessments to detect esophageal involvement during SSc is essential. Erosive GERD has been identified as a risk factor that contributes to the development of dysphagia and regurgitation in individuals with SSc. Keywords: esophageal involvement, esophageal manometry, esophagogastroduodenoscopy, 24-hour Impedance-pH Monitoring, systemic sclerosis Scleroderma is a rare connective tissue disorder recognized as an autoimmune disorder with a complex and unknown pathogenesis. The term "Scleroderma" originated in 1836 when Fantonetti, a Milanese physician, employed it to describe skin alterations in an adult individual. 1 There are two major forms of scleroderma: localized scleroderma, and systemic sclerosis. Localized scleroderma is a skin and subcutaneous tissue disease that leads to patches of thickened skin. 2 Systemic sclerosis (SSc), associated with severe morbidity and mortality, is characterized by gradual fibrosis of the skin and internal organs. 3 Despite its relatively low prevalence, SSc has the highest mortality rate of all rheumatic diseases. 4 SSc is classified into diffuse cutaneous SSc and limited cutaneous SSc. Diffuse cutaneous SSc shows a poor prognosis because of early and rapid organ involvement, whereas limited cutaneous SSc shows a better prognosis with slower disease progression and visceral involvement later in the disease course. 5 Systemic sclerosis (SSc) is a complex disease that affects not only the skin but also various organs, often leading to serious complications in the lungs and kidneys. In addition, some individuals experience musculoskeletal and cardiac problems. Gastrointestinal tract manifestations, including esophageal involvement, are observed in most patients. 6,7 However, there is limited understanding of the pathogenesis and risk factors for the development and predictors of esophageal disease progression in patients with SSc. Vasculopathy, 8 oxidative stress, fibrosis because of collagen deposition, 9 and autoantibody generation because of a dysregulated immune system may cause esophageal dysfunctions. 10 Epi -Abstract Truncated-

SSc-ILD: Reflux und Ösophagusdilatation keine Prädiktoren für Krankheitsverlauf

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Predictors of progression in systemic sclerosis patients with interstitial lung disease

Systemische Sklerose

34-jähriger Mann mit rheumatologischer Grunderkrankung

Interstitial Lung Disease Associated with Systemic Sclerosis

Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis

Journey into the Esophageal Complications: Decoding Systemic Sclerosis with Cutting-Edge Endoscopy, Manometry, and Ambulatory pH-Study

Expression of Epidermal Growth Factor receptor (EGFR) in Systemic Sclerosis patients (SSc) and Gastro-oesophageal Reflux Disease (GORD)

UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis

Characterisation of incident interstitial lung disease in late systemic sclerosis

The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease

Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology

The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database

Towards a more precise classification of esophageal motility disorders in patients with systemic sclerosis

Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis–Associated Interstitial Lung Disease

The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes

Gastrointestinal disease in systemic sclerosis: the neglected organ system?

KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD)

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease

Severity and impact of digestive impairment perceived by patients with systemic sclerosis: a cross-sectional study